Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
about
Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapy.Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.Protocol for a randomized controlled trial of early prophylactic feeding via gastrostomy versus standard care in high risk patients with head and neck cancer.Risk factors for late dysphagia after (chemo)radiotherapy for head and neck cancer: A systematic methodological review.Cine MRI of swallowing in patients with advanced oral or oropharyngeal carcinoma: a feasibility study.DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancerToxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.A swallow preservation protocol improves function for veterans receiving chemoradiation for head and neck cancerHow does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study.IMRT for head and neck cancer: reducing xerostomia and dysphagia.Organ-sparing radiation therapy for head and neck cancer.Emerging understanding of dosimetric factors impacting on dysphagia and nutrition following radiotherapy for oropharyngeal cancer.Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.Systematic review of dose--volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer.Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review.Hazards and risks in oncology: radiation oncology.Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: is it an underestimated phenomenon? A radiation oncologist's perspective.Improving guideline sensitivity and specificity for the identification of proactive gastrostomy placement in patients with head and neck cancer.Radiation-induced acute dysphagia : Prospective observational study on 42 head and neck cancer patients.Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer.Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer.Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.Delineation of the larynx as organ at risk in radiotherapy: a contouring course within "Rete Oncologica Piemonte-Valle d'Aosta" network to reduce inter- and intraobserver variability.Investigation of p16 status, chemotherapy regimen, and other nutrition markers for predicting gastrostomy in patients with head and neck cancer.
P2860
Q34564948-B8A278B3-04C9-4516-BF16-839A63BA923BQ35173132-00AE1365-3C73-42B5-8E9E-1E33A4811AC5Q35202870-1C54DB65-3F8A-4B89-A54E-19FCDE39AC97Q35532525-4951476D-2EA3-466B-8301-A6AFB13C91B0Q35936229-428965A9-4AB2-4E77-90FF-7F785152000BQ36156806-437BC075-76C2-41A7-B12D-34E88D0B1B6BQ36259231-574524FF-AB40-4DF6-8802-AA16E67F7388Q36623160-4ABAC7D8-734B-4AC4-A453-D08174A477F2Q37140870-6B002240-9F0E-453B-9061-C9C2CA57CC83Q37187245-C80691B7-FB32-4065-AA8C-04B7E172021CQ37905536-122B3225-6FB9-4530-9EEA-D5D9CD299523Q38021433-2FA0160A-D267-4E4F-859D-EBE694241CD1Q38074364-D999469F-2B19-4A75-B6FA-77A8F4796E70Q38083550-FBDCCD43-7342-4656-B510-E3567AE12C73Q38090999-2D3917F8-58C9-4CF7-830E-55F2BFD25845Q38119441-1BB13B55-7B6C-4C22-9645-662A5A070391Q38176904-8D3F0673-FF8F-4A47-B550-64D7FB8D62B1Q38446588-79693F65-8318-44EA-8BA2-642A30F90D9CQ38974851-1445AB1C-7C09-4238-B0F1-F294B8D07FD0Q40051688-B24FEFA4-8117-433D-8A69-FC71647F444DQ45767378-9DE21163-E7E5-44DB-807E-798318748657Q46119836-9F71B664-32C9-4BA0-9D87-D0EF2C6CADC3Q46326125-AFD1C60C-239F-47D8-A9C2-9F07F518EB37Q48157099-81DD7535-BE44-4E49-822E-01748E936974Q52902619-7E43A219-D7C2-4734-BF63-311DFA37896B
P2860
Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Clinical-dosimetric analysis o ...... with concurrent chemotherapy.
@en
Clinical-dosimetric analysis o ...... with concurrent chemotherapy.
@nl
type
label
Clinical-dosimetric analysis o ...... with concurrent chemotherapy.
@en
Clinical-dosimetric analysis o ...... with concurrent chemotherapy.
@nl
prefLabel
Clinical-dosimetric analysis o ...... with concurrent chemotherapy.
@en
Clinical-dosimetric analysis o ...... with concurrent chemotherapy.
@nl
P2093
P2860
P921
P356
P1433
P1476
Clinical-dosimetric analysis o ...... with concurrent chemotherapy.
@en
P2093
Allen M Chen
Baoqing Li
D Gregory Farwell
Derick H Lau
James A Purdy
Jean Courquin
Kathleen Newman
P2860
P2888
P356
10.1186/1748-717X-4-52
P577
2009-11-12T00:00:00Z
P6179
1030449010